IOVANCE BIOTHERAPEUTICS, INC. - IOVA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Interim CEO & General Counsel | M | D | 15,626.0 | 0.0 | 0.0 | 93,756.0 | View | |
| Sep 10, 2026 | Interim CEO & General Counsel | F | D | 6,638.0 | 8.7 | 57,750.6 | 595,447.0 | View | |
| Sep 10, 2026 | Interim CEO & General Counsel | M | A | 15,626.0 | 0.0 | 0.0 | 602,085.0 | View | |
| Sep 10, 2026 | Chief Operating Officer | M | D | 7,813.0 | 0.0 | 0.0 | 46,878.0 | View | |
| Sep 10, 2026 | Chief Operating Officer | F | D | 3,976.0 | 8.7 | 34,591.2 | 142,074.0 | View | |
| Sep 10, 2026 | Chief Operating Officer | M | A | 7,813.0 | 0.0 | 0.0 | 146,050.0 | View | |
| Sep 10, 2026 | Chief Regulatory Officer | M | D | 9,766.0 | 0.0 | 0.0 | 58,599.0 | View | |
| Sep 10, 2026 | Chief Regulatory Officer | F | D | 4,478.0 | 8.7 | 38,958.6 | 256,364.0 | View | |
| Sep 10, 2026 | Chief Regulatory Officer | M | A | 9,766.0 | 0.0 | 0.0 | 260,842.0 | View | |
| Sep 03, 2026 | Interim CEO & General Counsel | M | D | 41,669.0 | 0.0 | 0.0 | 83,338.0 | View | |
| Sep 03, 2026 | Interim CEO & General Counsel | F | D | 17,702.0 | 8.28 | 146,572.56 | 586,459.0 | View | |
| Sep 03, 2026 | Interim CEO & General Counsel | M | A | 41,669.0 | 0.0 | 0.0 | 604,161.0 | View | |
| Sep 03, 2026 | Chief Regulatory Officer | M | D | 5,470.0 | 0.0 | 0.0 | 10,939.0 | View | |
| Sep 03, 2026 | Chief Regulatory Officer | F | D | 2,508.0 | 8.28 | 20,766.24 | 251,076.0 | View | |
| Sep 03, 2026 | Chief Regulatory Officer | M | A | 5,470.0 | 0.0 | 0.0 | 253,584.0 | View | |
| Sep 03, 2026 | Chief Operating Officer | M | D | 8,789.0 | 0.0 | 0.0 | 17,580.0 | View | |
| Sep 03, 2026 | Chief Operating Officer | F | D | 4,472.0 | 8.28 | 37,028.16 | 138,237.0 | View | |
| Sep 03, 2026 | Chief Operating Officer | M | A | 8,789.0 | 0.0 | 0.0 | 142,709.0 | View | |
| Aug 12, 2026 | Chief Commercial Officer | M | D | 10,001.0 | 0.0 | 0.0 | 60,003.0 | View | |
| Aug 12, 2026 | Chief Commercial Officer | F | D | 2,436.0 | 6.4 | 15,590.4 | 154,511.0 | View | |
| Aug 12, 2026 | Chief Commercial Officer | M | A | 10,001.0 | 0.0 | 0.0 | 156,947.0 | View | |
| Aug 10, 2026 | Chief Financial Officer | M | D | 49,995.0 | 0.0 | 0.0 | 100,005.0 | View | |
| Aug 10, 2026 | Chief Financial Officer | F | D | 21,238.0 | 6.21 | 131,887.98 | 28,757.0 | View | |
| Aug 10, 2026 | Chief Financial Officer | M | A | 49,995.0 | 0.0 | 0.0 | 49,995.0 | View | |
| Jun 18, 2026 | — | A | A | 90,316.0 | 0.0 | 0.0 | 90,316.0 | View | |
| Jun 18, 2026 | — | A | A | 180,632.0 | 0.0 | 0.0 | 180,632.0 | View | |
| Jun 18, 2026 | — | A | A | 90,316.0 | 0.0 | 0.0 | 90,316.0 | View | |
| Jun 18, 2026 | — | A | A | 90,316.0 | 0.0 | 0.0 | 90,316.0 | View | |
| Jun 18, 2026 | Chief Regulatory Officer | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 09, 2026 | Interim CEO & General Counsel | M | D | 15,625.0 | 0.0 | 0.0 | 109,382.0 | View | |
| Jun 09, 2026 | Interim CEO & General Counsel | F | D | 6,638.0 | 4.23 | 28,078.74 | 562,492.0 | View | |
| Jun 09, 2026 | Interim CEO & General Counsel | M | A | 15,625.0 | 0.0 | 0.0 | 569,130.0 | View | |
| Jun 09, 2026 | Chief Medical Officer | M | D | 7,813.0 | 0.0 | 0.0 | 54,691.0 | View | |
| Jun 09, 2026 | Chief Medical Officer | F | D | 3,976.0 | 4.23 | 16,818.48 | 140,111.0 | View | |
| Jun 09, 2026 | Chief Medical Officer | M | A | 7,813.0 | 0.0 | 0.0 | 144,087.0 | View | |
| Jun 09, 2026 | Chief Regulatory Officer | M | D | 9,766.0 | 0.0 | 0.0 | 68,365.0 | View | |
| Jun 09, 2026 | Chief Regulatory Officer | F | D | 3,843.0 | 4.23 | 16,255.89 | 248,114.0 | View | |
| Jun 09, 2026 | Chief Regulatory Officer | M | A | 9,766.0 | 0.0 | 0.0 | 251,957.0 | View | |
| Jun 09, 2026 | Chief Operating Officer | M | D | 7,813.0 | 0.0 | 0.0 | 54,691.0 | View | |
| Jun 09, 2026 | Chief Operating Officer | F | D | 3,976.0 | 4.23 | 16,818.48 | 133,920.0 | View | |
| Jun 09, 2026 | Chief Operating Officer | M | A | 7,813.0 | 0.0 | 0.0 | 137,896.0 | View | |
| Jun 03, 2026 | Interim CEO & General Counsel | M | D | 41,668.0 | 0.0 | 0.0 | 125,007.0 | View | |
| Jun 03, 2026 | Interim CEO & General Counsel | F | D | 17,701.0 | 3.96 | 70,095.96 | 553,505.0 | View | |
| Jun 03, 2026 | Interim CEO & General Counsel | M | A | 41,668.0 | 0.0 | 0.0 | 571,206.0 | View | |
| Jun 03, 2026 | Chief Regulatory Officer | M | D | 5,469.0 | 0.0 | 0.0 | 16,409.0 | View | |
| Jun 03, 2026 | Chief Regulatory Officer | F | D | 2,508.0 | 3.96 | 9,931.68 | 242,191.0 | View | |
| Jun 03, 2026 | Chief Regulatory Officer | M | A | 5,469.0 | 0.0 | 0.0 | 244,699.0 | View | |
| Jun 03, 2026 | Chief Medical Officer | M | D | 8,790.0 | 0.0 | 0.0 | 26,369.0 | View | |
| Jun 03, 2026 | Chief Medical Officer | F | D | 4,473.0 | 3.96 | 17,713.08 | 136,274.0 | View | |
| Jun 03, 2026 | Chief Medical Officer | M | A | 8,790.0 | 0.0 | 0.0 | 140,747.0 | View | |
| Jun 03, 2026 | Chief Operating Officer | M | D | 8,790.0 | 0.0 | 0.0 | 26,369.0 | View | |
| Jun 03, 2026 | Chief Operating Officer | F | D | 4,473.0 | 3.96 | 17,713.08 | 130,083.0 | View | |
| Jun 03, 2026 | Chief Operating Officer | M | A | 8,790.0 | 0.0 | 0.0 | 134,556.0 | View | |
| May 13, 2026 | Chief Commercial Officer | M | D | 10,000.0 | 0.0 | 0.0 | 70,004.0 | View | |
| May 13, 2026 | Chief Commercial Officer | F | D | 2,435.0 | 3.7 | 9,009.5 | 146,946.0 | View | |
| May 13, 2026 | Chief Commercial Officer | M | A | 10,000.0 | 0.0 | 0.0 | 149,381.0 | View |